Phillipps University, Clinic for Psychiatry and Psychotherapy
Marburg, Hesse, 35039, Germany
NCT Number: NCT00997256
To demonstrate the influence of a herbal preparation containing hypericum, passionflower, and valerian on sleep structure, improvement of attention, and well-being in comparison to placebo.
Looking for future studies?
Notify Me18 year–55 year
Male
Interventional
Phase 1
Marburg, Hesse, 35039, Germany
To demonstrate the influence of the herbal combination preparation Neurapas® balance on the objective sleep structure in comparison with placebo. A further aim was to investigate whether treatment with Neurapas® balance versus placebo brings about an improvement in attention and well-being and whether these changes are related to the improvement in the sleep structure.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 x 2 tablets / day over 3 days
Other names: Neurapas balance, film-coated tablet over 3 days
3 x 2 tablets / day over 3 days
Time frame: Day 3 + 14
Time frame: Day 4 + 15
Time frame: Day 4 + 15
Time frame: Day 4 + 15
Time frame: Day 4 +15
Time frame: Day 4 + 15
Time frame: Day 4 + 15
Time frame: Day 4 + 15
Pascoe Pharmazeutische Praeparate GmbH
Industry
Phase I, Placebo-controlled, Double-blind, Randomised, Single-centre Study of Single Cross-over Design to Investigate the Effects of the Herbal Preparation Neurapas® Balance Compared With Placebo on Sleep EEG, Mental Performance and Well-being
Acronym: sleep-EEG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07667699
Atrophy, Bone Mineral Density
View Trial DetailsNCT04299490
Agnosia, Apnea
Baltimore, Maryland, United States
View Trial DetailsNCT06507969
Body Weight, Dyssomnias
Istanbul, Kagıthane-Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06510335
Dyssomnias, Healthy
Pleasant Grove, Utah, United States
View Trial Details